Pricing Log in Create free account

Evotec AG (EVO) vs Alpha Teknova, Inc. (TKNO)

Evotec AG and Alpha Teknova, Inc. are both Drug Manufacturers Specialty & Generic companies. Evotec AG is the larger, with a market value of $504.4M against $408.0M — 1.2× the size. Alpha Teknova, Inc. grew revenue faster over the last twelve months: 12.3% against 2.15%. Evotec AG has the higher net margin (−26.2% vs −38.4%) and the higher return on invested capital (0.00% vs −16.9%). Across the 18 metrics below, Evotec AG leads on 12 and Alpha Teknova, Inc. on 6.

Valuation

Metric EVO TKNO Drug Manufacturers Specialty & Generic median
P/E n/m n/m 19.25
P/S 0.57 8.69 2.11
P/B 0.63 6.07 1.78
Price to free cash flow n/m n/m 16.14
EV/EBITDA n/m n/m 12.58
EV/Sales 0.58 8.69 2.73
Earnings yield (46.23%) (4.38%) (4.38%)
Free cash flow yield (40.86%) (1.94%) 0.00%

Profitability

Metric EVO TKNO Drug Manufacturers Specialty & Generic median
Gross margin 11.42% 34.60% 53.94%
Operating margin (21.35%) (36.19%) 0.00%
Net margin (26.20%) (38.37%) 0.00%
Free cash flow margin 0.00% (16.83%) 0.00%
Return on equity 0.00% (24.19%) (0.40%)
Return on assets 0.00% (16.25%) (3.32%)
Return on invested capital 0.00% (16.93%) 0.00%

Growth

Metric EVO TKNO Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 2.15% 12.27% 10.01%
EPS growth (last fiscal year) 44.89% 43.86% 49.06%
Revenue growth, 5-year CAGR 9.28% 5.30% 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric EVO TKNO Drug Manufacturers Specialty & Generic median
Debt to equity 0.72 0.21 0.05
Current ratio 2.33 4.49 2.31
Net debt to EBITDA (0.64) 0.75 0.97

Dividend

Metric EVO TKNO Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.57%
Payout ratio — — 0.27

Size

Metric EVO TKNO Drug Manufacturers Specialty & Generic median
Market cap 504.36m 408.03m 276.90m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack